However, lactoferrin clearly activates the expression of PI3K, AKT, and ERK1/2 in HUVECs, suggesting that it is a dual regulatory molecule, inhibiting tumor cells but activating normal endothelial cells. The gene discussed is LTF; the disease is neoplasm.